Quick Answer
DailyMed lists tesamorelin's mean elimination half-life as 8 minutes after a single 1.4 mg subcutaneous EGRIFTA SV dose in healthy subjects. It also lists a median peak time of 0.15 hours, which is about nine minutes.
That short half-life is easy to misread. Tesamorelin is a signaling peptide, not a drug that needs to sit in circulation all day to matter. It stimulates growth hormone release and increases IGF-1 and IGFBP-3, so the downstream endocrine response is the real story. The molecule clears quickly; the biological signal is why repeated daily use can still produce meaningful body-composition changes over months.
Explore the AminoRank tesamorelin profileReview linked studies, category details, and vendor availability for tesamorelin.View tesamorelin profileThe Label Half-Life
The EGRIFTA SV label gives a clear pharmacokinetic answer: mean elimination half-life was 8 minutes after a single 1.4 mg subcutaneous dose in healthy subjects.
The label also reports a median Tmax of 0.15 hours, which means peak plasma concentration happens quickly. In other words, the molecule appears and clears fast, while the hormonal signal it triggers can matter beyond that short plasma window.
| Pharmacokinetic point | Label context |
|---|---|
| Mean elimination half-life | 8 minutes after 1.4 mg EGRIFTA SV in healthy subjects. |
| Median Tmax | 0.15 hours after 1.4 mg EGRIFTA SV. |
| Route | Subcutaneous injection. |
| Downstream effect | Increases GH, IGF-1, and IGFBP-3. |
Why Short Half-Life Does Not Mean Short Results
Tesamorelin works by signaling the pituitary. Once that signal triggers growth hormone release, the downstream hormone cascade matters. The molecule itself can clear quickly while GH and IGF-1 biology continue to carry the message.
That is why half-life should not be confused with cycle length or result duration. Plasma pharmacokinetics are measured in minutes. Clinical body-composition changes were measured over months in the studies that made tesamorelin important. In other words, the 8-minute half-life does not weaken the tesamorelin case. It explains why the peptide acts like a signal rather than a long-lasting circulating drug.
How Tesamorelin Works
Tesamorelin binds and stimulates human growth-hormone-releasing factor receptors. GHRH acts on pituitary somatotroph cells to stimulate synthesis and pulsatile release of endogenous growth hormone.
Growth hormone then acts on multiple tissues, including adipose tissue, and some effects are mediated through IGF-1. This is the mechanism that connects a short-lived peptide signal to longer body-composition outcomes. It also explains why tesamorelin is usually discussed differently from direct HGH: the peptide pushes the body's own GH-release pathway rather than supplying growth hormone itself.
Half-Life Versus Dosing Frequency
The label dosing context is once daily, despite the short half-life. That can seem strange until you separate signaling from drug persistence. Tesamorelin does not need to remain high in plasma all day to act as a daily releasing-hormone signal.
This is similar to how many hormones and signaling peptides work. The pulse matters. The clinical interest comes from repeating that signal consistently enough for downstream changes in visceral fat and related body-composition measures to show up over time.
Half-Life Versus Vial Math
Half-life tells you about elimination. It does not tell you how long a vial lasts, how many syringe units equal an amount, or how to plan research concentration. A 5 mg or 10 mg vial is an inventory question. Half-life is a pharmacokinetic question.
Use the peptide calculatorCalculate concentration and syringe-unit math for research planning.Open calculatorProduct Context
The half-life discussion only matters if the product is actually what the listing says it is. For research listings, that makes the basics worth checking: compound name, vial amount, COA signal, reviews, and whether the vendor profile is detailed enough to compare.
Tesamorelin Vendors With COA Signals
View all Tesamorelin vendors| Vendor | Country | COAs | Rating | Reviews | Notes | Website |
|---|---|---|---|---|---|---|
| LA Peptides | USA | Yes | 5.0 | 1 | Verified listing | Buy |
| NextGenPeps | USA | Yes | 5.0 | 1 | Verified listing | Buy |
| Alpha Peptides | USA | Yes | 0.0 | 0 | Verified listing | Buy |
| Ascension Peptides | USA | Yes | 0.0 | 0 | Verified listing | Buy |
| BioCollex | USA | Yes | 0.0 | 0 | Verified listing | Buy |
| Coastal Peptides | USA | Yes | 0.0 | 0 | Verified listing | Buy |
FAQ
Is tesamorelin fast acting?
It peaks quickly in plasma, but visible body-composition changes are not immediate.
Why is tesamorelin taken daily if the half-life is short?
Because it acts as a daily signaling peptide through GH release rather than a long-lasting plasma drug.
Does tesamorelin half-life affect results?
Half-life helps explain pharmacokinetics, but results depend on repeated exposure and downstream GH/IGF-1 response.
Is half-life the same as how long a vial lasts?
No. Vial duration depends on vial amount, concentration, and measurement math.